{"id":10567,"date":"2024-08-02T17:21:41","date_gmt":"2024-08-02T11:51:41","guid":{"rendered":"https:\/\/cliqindia.com\/japanese\/?p=10567"},"modified":"2024-08-02T17:21:41","modified_gmt":"2024-08-02T11:51:41","slug":"japans-first-preventive-anti-hiv-drug-truvada-to-be-approved","status":"publish","type":"post","link":"https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/","title":{"rendered":"\u56fd\u5185\u521d\u306e\u4e88\u9632\u76ee\u7684\u6297HIV\u85ac\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u627f\u8a8d\u3078 | BulletsIn"},"content":{"rendered":"<p>\u539a\u751f\u52b4\u50cd\u7701\u306e\u5c02\u9580\u5bb6\u90e8\u4f1a\u306f\u3001\u30a8\u30a4\u30ba\u306e\u539f\u56e0\u3068\u306a\u308b\u30d2\u30c8\u514d\u75ab\u4e0d\u5168\u30a6\u30a4\u30eb\u30b9\uff08HIV\uff09\u306b\u5bfe\u3059\u308b\u6297HIV\u85ac\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u3092\u611f\u67d3\u4e88\u9632\u76ee\u7684\u3067\u4f7f\u7528\u3059\u308b\u3053\u3068\u3092\u627f\u8a8d\u3059\u308b\u65b9\u91dd\u3092\u6c7a\u5b9a\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u306f\u65e5\u672c\u56fd\u5185\u3067\u521d\u3081\u3066\u4e88\u9632\u76ee\u7684\u3067\u4f7f\u7528\u3055\u308c\u308b\u6297HIV\u85ac\u3068\u306a\u308a\u307e\u3059\u3002<\/p>\n<h2><strong>BulletsIn<\/strong><\/h2>\n<ul>\n<li>\u539a\u751f\u52b4\u50cd\u7701\u306e\u5c02\u9580\u5bb6\u90e8\u4f1a\u304c\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u306e\u4e88\u9632\u76ee\u7684\u3067\u306e\u4f7f\u7528\u3092\u627f\u8a8d\u3002<\/li>\n<li>\u3053\u306e\u627f\u8a8d\u304c\u6b63\u5f0f\u306b\u6c7a\u5b9a\u3055\u308c\u308c\u3070\u3001\u65e5\u672c\u56fd\u5185\u521d\u306e\u4e88\u9632\u76ee\u7684\u6297HIV\u85ac\u3068\u306a\u308b\u3002<\/li>\n<li>\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u306fHIV\u611f\u67d3\u3092\u9632\u3050\u305f\u3081\u306b\u4f7f\u308f\u308c\u308b\u3002<\/li>\n<li>\u4e88\u9632\u76ee\u7684\u3067\u306e\u6297HIV\u85ac\u4f7f\u7528\u306f\u3001\u4e16\u754c\u7684\u306b\u666e\u53ca\u3057\u3066\u3044\u308b\u3002<\/li>\n<li>\u7c73\u75be\u75c5\u5bfe\u7b56\u30bb\u30f3\u30bf\u30fc\uff08CDC\uff09\u306f\u3001\u6b63\u3057\u304f\u4f7f\u7528\u3059\u308c\u3070\u6027\u884c\u70ba\u306b\u3088\u308b\u611f\u67d3\u30ea\u30b9\u30af\u304c99%\u6e1b\u5c11\u3059\u308b\u3068\u5831\u544a\u3002<\/li>\n<li>\u4e16\u754c\u4fdd\u5065\u6a5f\u95a2\uff08WHO\uff09\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3067\u3082\u3001\u4e88\u9632\u76ee\u7684\u3067\u306e\u6297HIV\u85ac\u4f7f\u7528\u304c\u63a8\u5968\u3055\u308c\u3066\u3044\u308b\u3002<\/li>\n<li>\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u306f\u73fe\u5728\u3001HIV\u611f\u67d3\u8005\u3078\u306e\u6cbb\u7642\u85ac\u3068\u3057\u3066\u3082\u4f7f\u308f\u308c\u3066\u3044\u308b\u3002<\/li>\n<li>\u4e88\u9632\u4f7f\u7528\u306e\u627f\u8a8d\u306b\u3088\u308a\u3001HIV\u306e\u65b0\u898f\u611f\u67d3\u8005\u6570\u306e\u6e1b\u5c11\u304c\u671f\u5f85\u3055\u308c\u308b\u3002<\/li>\n<li>\u65e5\u672c\u3067\u306e\u4e88\u9632\u76ee\u7684\u4f7f\u7528\u306b\u5411\u3051\u305f\u52d5\u304d\u306f\u3001HIV\u5bfe\u7b56\u306e\u5f37\u5316\u3092\u610f\u5473\u3059\u308b\u3002<\/li>\n<li>\u4eca\u5f8c\u3001\u5177\u4f53\u7684\u306a\u4f7f\u7528\u65b9\u6cd5\u3084\u63a8\u5968\u5bfe\u8c61\u8005\u306b\u3064\u3044\u3066\u306e\u8a73\u7d30\u306a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u304c\u767a\u8868\u3055\u308c\u308b\u898b\u8fbc\u307f\u3002<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>\u539a\u751f\u52b4\u50cd\u7701\u306e\u5c02\u9580\u5bb6\u90e8\u4f1a\u306f\u3001\u30a8\u30a4\u30ba\u306e\u539f\u56e0\u3068\u306a\u308b\u30d2\u30c8\u514d\u75ab\u4e0d\u5168\u30a6\u30a4\u30eb\u30b9\uff08HIV\uff09\u306b\u5bfe\u3059\u308b\u6297HIV\u85ac\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u3092\u611f\u67d3\u4e88\u9632\u76ee\u7684\u3067\u4f7f\u7528\u3059\u308b\u3053\u3068\u3092\u627f\u8a8d\u3059\u308b\u65b9\u91dd\u3092\u6c7a\u5b9a\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u306f\u65e5\u672c\u56fd\u5185\u3067\u521d\u3081\u3066\u4e88\u9632\u76ee\u7684\u3067\u4f7f\u7528\u3055\u308c\u308b\u6297HIV\u85ac\u3068\u306a\u308a\u307e\u3059\u3002 BulletsIn \u539a\u751f\u52b4\u50cd\u7701\u306e\u5c02\u9580\u5bb6\u90e8\u4f1a\u304c\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u306e\u4e88\u9632\u76ee\u7684\u3067\u306e\u4f7f\u7528\u3092\u627f\u8a8d\u3002 \u3053\u306e\u627f\u8a8d\u304c\u6b63\u5f0f\u306b\u6c7a\u5b9a\u3055\u308c\u308c\u3070\u3001\u65e5\u672c\u56fd\u5185\u521d\u306e\u4e88\u9632\u76ee\u7684\u6297HIV\u85ac\u3068\u306a\u308b\u3002 \u300c\u30c4\u30eb\u30d0\u30c0\u300d\u306fHIV\u611f\u67d3\u3092\u9632\u3050\u305f\u3081\u306b\u4f7f\u308f\u308c\u308b\u3002 \u4e88\u9632\u76ee\u7684\u3067\u306e\u6297HIV\u85ac\u4f7f\u7528\u306f\u3001\u4e16\u754c\u7684\u306b\u666e\u53ca\u3057\u3066\u3044\u308b\u3002 \u7c73\u75be\u75c5\u5bfe\u7b56\u30bb\u30f3\u30bf\u30fc\uff08CDC\uff09\u306f\u3001\u6b63\u3057\u304f\u4f7f\u7528\u3059\u308c\u3070\u6027\u884c\u70ba\u306b\u3088\u308b\u611f\u67d3\u30ea\u30b9\u30af\u304c99%\u6e1b\u5c11\u3059\u308b\u3068\u5831\u544a\u3002 \u4e16\u754c\u4fdd\u5065\u6a5f\u95a2\uff08WHO\uff09\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3067\u3082\u3001\u4e88\u9632\u76ee\u7684\u3067\u306e\u6297HIV\u85ac\u4f7f\u7528\u304c\u63a8\u5968\u3055\u308c\u3066\u3044\u308b\u3002 \u300c\u30c4\u30eb\u30d0\u30c0\u300d\u306f\u73fe\u5728\u3001HIV\u611f\u67d3\u8005\u3078\u306e\u6cbb\u7642\u85ac\u3068\u3057\u3066\u3082\u4f7f\u308f\u308c\u3066\u3044\u308b\u3002 \u4e88\u9632\u4f7f\u7528\u306e\u627f\u8a8d\u306b\u3088\u308a\u3001HIV\u306e\u65b0\u898f\u611f\u67d3\u8005\u6570\u306e\u6e1b\u5c11\u304c\u671f\u5f85\u3055\u308c\u308b\u3002 \u65e5\u672c\u3067\u306e\u4e88\u9632\u76ee\u7684\u4f7f\u7528\u306b\u5411\u3051\u305f\u52d5\u304d\u306f\u3001HIV\u5bfe\u7b56\u306e\u5f37\u5316\u3092\u610f\u5473\u3059\u308b\u3002 \u4eca\u5f8c\u3001\u5177\u4f53\u7684\u306a\u4f7f\u7528\u65b9\u6cd5\u3084\u63a8\u5968\u5bfe\u8c61\u8005\u306b\u3064\u3044\u3066\u306e\u8a73\u7d30\u306a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u304c\u767a\u8868\u3055\u308c\u308b\u898b\u8fbc\u307f\u3002<\/p>\n","protected":false},"author":33,"featured_media":10568,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[2189,2690,2689],"class_list":["post-10567","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-bulletsin","tag-hivprevention","tag-prepapproval"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u56fd\u5185\u521d\u306e\u4e88\u9632\u76ee\u7684\u6297HIV\u85ac\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u627f\u8a8d\u3078 | BulletsIn - cliQ India Japanese<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u56fd\u5185\u521d\u306e\u4e88\u9632\u76ee\u7684\u6297HIV\u85ac\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u627f\u8a8d\u3078 | BulletsIn - cliQ India Japanese\" \/>\n<meta property=\"og:description\" content=\"\u539a\u751f\u52b4\u50cd\u7701\u306e\u5c02\u9580\u5bb6\u90e8\u4f1a\u306f\u3001\u30a8\u30a4\u30ba\u306e\u539f\u56e0\u3068\u306a\u308b\u30d2\u30c8\u514d\u75ab\u4e0d\u5168\u30a6\u30a4\u30eb\u30b9\uff08HIV\uff09\u306b\u5bfe\u3059\u308b\u6297HIV\u85ac\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u3092\u611f\u67d3\u4e88\u9632\u76ee\u7684\u3067\u4f7f\u7528\u3059\u308b\u3053\u3068\u3092\u627f\u8a8d\u3059\u308b\u65b9\u91dd\u3092\u6c7a\u5b9a\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u306f\u65e5\u672c\u56fd\u5185\u3067\u521d\u3081\u3066\u4e88\u9632\u76ee\u7684\u3067\u4f7f\u7528\u3055\u308c\u308b\u6297HIV\u85ac\u3068\u306a\u308a\u307e\u3059\u3002 BulletsIn \u539a\u751f\u52b4\u50cd\u7701\u306e\u5c02\u9580\u5bb6\u90e8\u4f1a\u304c\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u306e\u4e88\u9632\u76ee\u7684\u3067\u306e\u4f7f\u7528\u3092\u627f\u8a8d\u3002 \u3053\u306e\u627f\u8a8d\u304c\u6b63\u5f0f\u306b\u6c7a\u5b9a\u3055\u308c\u308c\u3070\u3001\u65e5\u672c\u56fd\u5185\u521d\u306e\u4e88\u9632\u76ee\u7684\u6297HIV\u85ac\u3068\u306a\u308b\u3002 \u300c\u30c4\u30eb\u30d0\u30c0\u300d\u306fHIV\u611f\u67d3\u3092\u9632\u3050\u305f\u3081\u306b\u4f7f\u308f\u308c\u308b\u3002 \u4e88\u9632\u76ee\u7684\u3067\u306e\u6297HIV\u85ac\u4f7f\u7528\u306f\u3001\u4e16\u754c\u7684\u306b\u666e\u53ca\u3057\u3066\u3044\u308b\u3002 \u7c73\u75be\u75c5\u5bfe\u7b56\u30bb\u30f3\u30bf\u30fc\uff08CDC\uff09\u306f\u3001\u6b63\u3057\u304f\u4f7f\u7528\u3059\u308c\u3070\u6027\u884c\u70ba\u306b\u3088\u308b\u611f\u67d3\u30ea\u30b9\u30af\u304c99%\u6e1b\u5c11\u3059\u308b\u3068\u5831\u544a\u3002 \u4e16\u754c\u4fdd\u5065\u6a5f\u95a2\uff08WHO\uff09\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3067\u3082\u3001\u4e88\u9632\u76ee\u7684\u3067\u306e\u6297HIV\u85ac\u4f7f\u7528\u304c\u63a8\u5968\u3055\u308c\u3066\u3044\u308b\u3002 \u300c\u30c4\u30eb\u30d0\u30c0\u300d\u306f\u73fe\u5728\u3001HIV\u611f\u67d3\u8005\u3078\u306e\u6cbb\u7642\u85ac\u3068\u3057\u3066\u3082\u4f7f\u308f\u308c\u3066\u3044\u308b\u3002 \u4e88\u9632\u4f7f\u7528\u306e\u627f\u8a8d\u306b\u3088\u308a\u3001HIV\u306e\u65b0\u898f\u611f\u67d3\u8005\u6570\u306e\u6e1b\u5c11\u304c\u671f\u5f85\u3055\u308c\u308b\u3002 \u65e5\u672c\u3067\u306e\u4e88\u9632\u76ee\u7684\u4f7f\u7528\u306b\u5411\u3051\u305f\u52d5\u304d\u306f\u3001HIV\u5bfe\u7b56\u306e\u5f37\u5316\u3092\u610f\u5473\u3059\u308b\u3002 \u4eca\u5f8c\u3001\u5177\u4f53\u7684\u306a\u4f7f\u7528\u65b9\u6cd5\u3084\u63a8\u5968\u5bfe\u8c61\u8005\u306b\u3064\u3044\u3066\u306e\u8a73\u7d30\u306a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u304c\u767a\u8868\u3055\u308c\u308b\u898b\u8fbc\u307f\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/\" \/>\n<meta property=\"og:site_name\" content=\"cliQ India Japanese\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cliqindiamedia\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-02T11:51:41+00:00\" \/>\n<meta name=\"author\" content=\"cliQ India\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@cliqindiamedia\" \/>\n<meta name=\"twitter:site\" content=\"@cliqindiamedia\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"cliQ India\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/health\\\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\\\/10567\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/health\\\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\\\/10567\\\/\"},\"author\":{\"name\":\"cliQ India\",\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/#\\\/schema\\\/person\\\/3f5669594a6eba2d8af7171cbd0f7879\"},\"headline\":\"\u56fd\u5185\u521d\u306e\u4e88\u9632\u76ee\u7684\u6297HIV\u85ac\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u627f\u8a8d\u3078 | BulletsIn\",\"datePublished\":\"2024-08-02T11:51:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/health\\\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\\\/10567\\\/\"},\"wordCount\":15,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/health\\\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\\\/10567\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/wp-content\\\/uploads\\\/sites\\\/23\\\/2024\\\/08\\\/bullets-in-2024-08-02T172118.563-pdf.jpg\",\"keywords\":[\"BulletsIn\",\"HIVPrevention\",\"PrEPApproval\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/health\\\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\\\/10567\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/health\\\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\\\/10567\\\/\",\"url\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/health\\\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\\\/10567\\\/\",\"name\":\"\u56fd\u5185\u521d\u306e\u4e88\u9632\u76ee\u7684\u6297HIV\u85ac\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u627f\u8a8d\u3078 | BulletsIn - cliQ India Japanese\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/health\\\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\\\/10567\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/health\\\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\\\/10567\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/wp-content\\\/uploads\\\/sites\\\/23\\\/2024\\\/08\\\/bullets-in-2024-08-02T172118.563-pdf.jpg\",\"datePublished\":\"2024-08-02T11:51:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/health\\\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\\\/10567\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/health\\\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\\\/10567\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/health\\\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\\\/10567\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/wp-content\\\/uploads\\\/sites\\\/23\\\/2024\\\/08\\\/bullets-in-2024-08-02T172118.563-pdf.jpg\",\"contentUrl\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/wp-content\\\/uploads\\\/sites\\\/23\\\/2024\\\/08\\\/bullets-in-2024-08-02T172118.563-pdf.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/health\\\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\\\/10567\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u56fd\u5185\u521d\u306e\u4e88\u9632\u76ee\u7684\u6297HIV\u85ac\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u627f\u8a8d\u3078 | BulletsIn\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/#website\",\"url\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/\",\"name\":\"cliQ India Japanese\",\"description\":\"Japanese News ! Just a CliQ away\",\"publisher\":{\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/#organization\",\"name\":\"CliQ India\",\"url\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/cliqindia.com\\\/japanese\\\/wp-content\\\/uploads\\\/sites\\\/23\\\/2023\\\/09\\\/cropped-cliQ-favicon.png?fit=512%2C512&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/cliqindia.com\\\/japanese\\\/wp-content\\\/uploads\\\/sites\\\/23\\\/2023\\\/09\\\/cropped-cliQ-favicon.png?fit=512%2C512&ssl=1\",\"width\":512,\"height\":512,\"caption\":\"CliQ India\"},\"image\":{\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/cliqindiamedia\",\"https:\\\/\\\/x.com\\\/cliqindiamedia\",\"http:\\\/\\\/instagram.com\\\/cliqindiamedia\",\"https:\\\/\\\/www.kooapp.com\\\/profile\\\/cliqindia\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cliqindia.org\\\/japanese\\\/#\\\/schema\\\/person\\\/3f5669594a6eba2d8af7171cbd0f7879\",\"name\":\"cliQ India\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bd8df389f0e39735c26b1391681e349313c357b12b72cfa7f611514cbbd8d178?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bd8df389f0e39735c26b1391681e349313c357b12b72cfa7f611514cbbd8d178?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bd8df389f0e39735c26b1391681e349313c357b12b72cfa7f611514cbbd8d178?s=96&d=mm&r=g\",\"caption\":\"cliQ India\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u56fd\u5185\u521d\u306e\u4e88\u9632\u76ee\u7684\u6297HIV\u85ac\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u627f\u8a8d\u3078 | BulletsIn - cliQ India Japanese","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/","og_locale":"en_US","og_type":"article","og_title":"\u56fd\u5185\u521d\u306e\u4e88\u9632\u76ee\u7684\u6297HIV\u85ac\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u627f\u8a8d\u3078 | BulletsIn - cliQ India Japanese","og_description":"\u539a\u751f\u52b4\u50cd\u7701\u306e\u5c02\u9580\u5bb6\u90e8\u4f1a\u306f\u3001\u30a8\u30a4\u30ba\u306e\u539f\u56e0\u3068\u306a\u308b\u30d2\u30c8\u514d\u75ab\u4e0d\u5168\u30a6\u30a4\u30eb\u30b9\uff08HIV\uff09\u306b\u5bfe\u3059\u308b\u6297HIV\u85ac\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u3092\u611f\u67d3\u4e88\u9632\u76ee\u7684\u3067\u4f7f\u7528\u3059\u308b\u3053\u3068\u3092\u627f\u8a8d\u3059\u308b\u65b9\u91dd\u3092\u6c7a\u5b9a\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u306f\u65e5\u672c\u56fd\u5185\u3067\u521d\u3081\u3066\u4e88\u9632\u76ee\u7684\u3067\u4f7f\u7528\u3055\u308c\u308b\u6297HIV\u85ac\u3068\u306a\u308a\u307e\u3059\u3002 BulletsIn \u539a\u751f\u52b4\u50cd\u7701\u306e\u5c02\u9580\u5bb6\u90e8\u4f1a\u304c\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u306e\u4e88\u9632\u76ee\u7684\u3067\u306e\u4f7f\u7528\u3092\u627f\u8a8d\u3002 \u3053\u306e\u627f\u8a8d\u304c\u6b63\u5f0f\u306b\u6c7a\u5b9a\u3055\u308c\u308c\u3070\u3001\u65e5\u672c\u56fd\u5185\u521d\u306e\u4e88\u9632\u76ee\u7684\u6297HIV\u85ac\u3068\u306a\u308b\u3002 \u300c\u30c4\u30eb\u30d0\u30c0\u300d\u306fHIV\u611f\u67d3\u3092\u9632\u3050\u305f\u3081\u306b\u4f7f\u308f\u308c\u308b\u3002 \u4e88\u9632\u76ee\u7684\u3067\u306e\u6297HIV\u85ac\u4f7f\u7528\u306f\u3001\u4e16\u754c\u7684\u306b\u666e\u53ca\u3057\u3066\u3044\u308b\u3002 \u7c73\u75be\u75c5\u5bfe\u7b56\u30bb\u30f3\u30bf\u30fc\uff08CDC\uff09\u306f\u3001\u6b63\u3057\u304f\u4f7f\u7528\u3059\u308c\u3070\u6027\u884c\u70ba\u306b\u3088\u308b\u611f\u67d3\u30ea\u30b9\u30af\u304c99%\u6e1b\u5c11\u3059\u308b\u3068\u5831\u544a\u3002 \u4e16\u754c\u4fdd\u5065\u6a5f\u95a2\uff08WHO\uff09\u306e\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u3067\u3082\u3001\u4e88\u9632\u76ee\u7684\u3067\u306e\u6297HIV\u85ac\u4f7f\u7528\u304c\u63a8\u5968\u3055\u308c\u3066\u3044\u308b\u3002 \u300c\u30c4\u30eb\u30d0\u30c0\u300d\u306f\u73fe\u5728\u3001HIV\u611f\u67d3\u8005\u3078\u306e\u6cbb\u7642\u85ac\u3068\u3057\u3066\u3082\u4f7f\u308f\u308c\u3066\u3044\u308b\u3002 \u4e88\u9632\u4f7f\u7528\u306e\u627f\u8a8d\u306b\u3088\u308a\u3001HIV\u306e\u65b0\u898f\u611f\u67d3\u8005\u6570\u306e\u6e1b\u5c11\u304c\u671f\u5f85\u3055\u308c\u308b\u3002 \u65e5\u672c\u3067\u306e\u4e88\u9632\u76ee\u7684\u4f7f\u7528\u306b\u5411\u3051\u305f\u52d5\u304d\u306f\u3001HIV\u5bfe\u7b56\u306e\u5f37\u5316\u3092\u610f\u5473\u3059\u308b\u3002 \u4eca\u5f8c\u3001\u5177\u4f53\u7684\u306a\u4f7f\u7528\u65b9\u6cd5\u3084\u63a8\u5968\u5bfe\u8c61\u8005\u306b\u3064\u3044\u3066\u306e\u8a73\u7d30\u306a\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u304c\u767a\u8868\u3055\u308c\u308b\u898b\u8fbc\u307f\u3002","og_url":"https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/","og_site_name":"cliQ India Japanese","article_publisher":"https:\/\/www.facebook.com\/cliqindiamedia","article_published_time":"2024-08-02T11:51:41+00:00","author":"cliQ India","twitter_card":"summary_large_image","twitter_creator":"@cliqindiamedia","twitter_site":"@cliqindiamedia","twitter_misc":{"Written by":"cliQ India","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/#article","isPartOf":{"@id":"https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/"},"author":{"name":"cliQ India","@id":"https:\/\/cliqindia.org\/japanese\/#\/schema\/person\/3f5669594a6eba2d8af7171cbd0f7879"},"headline":"\u56fd\u5185\u521d\u306e\u4e88\u9632\u76ee\u7684\u6297HIV\u85ac\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u627f\u8a8d\u3078 | BulletsIn","datePublished":"2024-08-02T11:51:41+00:00","mainEntityOfPage":{"@id":"https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/"},"wordCount":15,"commentCount":0,"publisher":{"@id":"https:\/\/cliqindia.org\/japanese\/#organization"},"image":{"@id":"https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/#primaryimage"},"thumbnailUrl":"https:\/\/cliqindia.org\/japanese\/wp-content\/uploads\/sites\/23\/2024\/08\/bullets-in-2024-08-02T172118.563-pdf.jpg","keywords":["BulletsIn","HIVPrevention","PrEPApproval"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/","url":"https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/","name":"\u56fd\u5185\u521d\u306e\u4e88\u9632\u76ee\u7684\u6297HIV\u85ac\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u627f\u8a8d\u3078 | BulletsIn - cliQ India Japanese","isPartOf":{"@id":"https:\/\/cliqindia.org\/japanese\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/#primaryimage"},"image":{"@id":"https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/#primaryimage"},"thumbnailUrl":"https:\/\/cliqindia.org\/japanese\/wp-content\/uploads\/sites\/23\/2024\/08\/bullets-in-2024-08-02T172118.563-pdf.jpg","datePublished":"2024-08-02T11:51:41+00:00","breadcrumb":{"@id":"https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/#primaryimage","url":"https:\/\/cliqindia.org\/japanese\/wp-content\/uploads\/sites\/23\/2024\/08\/bullets-in-2024-08-02T172118.563-pdf.jpg","contentUrl":"https:\/\/cliqindia.org\/japanese\/wp-content\/uploads\/sites\/23\/2024\/08\/bullets-in-2024-08-02T172118.563-pdf.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/cliqindia.org\/japanese\/health\/japans-first-preventive-anti-hiv-drug-truvada-to-be-approved\/10567\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cliqindia.org\/japanese\/"},{"@type":"ListItem","position":2,"name":"\u56fd\u5185\u521d\u306e\u4e88\u9632\u76ee\u7684\u6297HIV\u85ac\u300c\u30c4\u30eb\u30d0\u30c0\u300d\u627f\u8a8d\u3078 | BulletsIn"}]},{"@type":"WebSite","@id":"https:\/\/cliqindia.org\/japanese\/#website","url":"https:\/\/cliqindia.org\/japanese\/","name":"cliQ India Japanese","description":"Japanese News ! Just a CliQ away","publisher":{"@id":"https:\/\/cliqindia.org\/japanese\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cliqindia.org\/japanese\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cliqindia.org\/japanese\/#organization","name":"CliQ India","url":"https:\/\/cliqindia.org\/japanese\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cliqindia.org\/japanese\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/cliqindia.com\/japanese\/wp-content\/uploads\/sites\/23\/2023\/09\/cropped-cliQ-favicon.png?fit=512%2C512&ssl=1","contentUrl":"https:\/\/i0.wp.com\/cliqindia.com\/japanese\/wp-content\/uploads\/sites\/23\/2023\/09\/cropped-cliQ-favicon.png?fit=512%2C512&ssl=1","width":512,"height":512,"caption":"CliQ India"},"image":{"@id":"https:\/\/cliqindia.org\/japanese\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cliqindiamedia","https:\/\/x.com\/cliqindiamedia","http:\/\/instagram.com\/cliqindiamedia","https:\/\/www.kooapp.com\/profile\/cliqindia"]},{"@type":"Person","@id":"https:\/\/cliqindia.org\/japanese\/#\/schema\/person\/3f5669594a6eba2d8af7171cbd0f7879","name":"cliQ India","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/bd8df389f0e39735c26b1391681e349313c357b12b72cfa7f611514cbbd8d178?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bd8df389f0e39735c26b1391681e349313c357b12b72cfa7f611514cbbd8d178?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd8df389f0e39735c26b1391681e349313c357b12b72cfa7f611514cbbd8d178?s=96&d=mm&r=g","caption":"cliQ India"}}]}},"featured":"0","video_post":"0","video_url":false,"youtube_url":"","vimeo_url":"","_links":{"self":[{"href":"https:\/\/cliqindia.org\/japanese\/wp-json\/wp\/v2\/posts\/10567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cliqindia.org\/japanese\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cliqindia.org\/japanese\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cliqindia.org\/japanese\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/cliqindia.org\/japanese\/wp-json\/wp\/v2\/comments?post=10567"}],"version-history":[{"count":1,"href":"https:\/\/cliqindia.org\/japanese\/wp-json\/wp\/v2\/posts\/10567\/revisions"}],"predecessor-version":[{"id":10569,"href":"https:\/\/cliqindia.org\/japanese\/wp-json\/wp\/v2\/posts\/10567\/revisions\/10569"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cliqindia.org\/japanese\/wp-json\/wp\/v2\/media\/10568"}],"wp:attachment":[{"href":"https:\/\/cliqindia.org\/japanese\/wp-json\/wp\/v2\/media?parent=10567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cliqindia.org\/japanese\/wp-json\/wp\/v2\/categories?post=10567"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cliqindia.org\/japanese\/wp-json\/wp\/v2\/tags?post=10567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}